Nihon Iyakuhin Kogyo

Nihon Iyakuhin Kogyo is a Japanese pharmaceutical company specializing in the manufacturing and distribution of generic medicines, over-the-counter (OTC) drugs, and quasi-drugs. Based in Toyama, the company operates as a core manufacturing subsidiary within the Towa Pharmaceutical Group, following its acquisition from Mitsubishi Tanabe Pharma in 2021. Its production facilities are equipped to handle various dosage forms, including oral tablets, capsules, and external preparations, adhering to strict GMP standards. The company plays a vital role in the Japanese healthcare system by ensuring a stable supply of high-quality, affordable generic versions of essential medications across multiple therapeutic areas such as cardiovascular and metabolic health. Its integration into the Towa Pharmaceutical Group has strengthened the group's overall production capacity and supply chain resilience in the generic drug market.